Time to Treatment Initiation and HIV Viral Suppression in People Diagnosed With HIV-1 During COVID-19 Pandemic in Ex-Aquitaine, France (ANRS CO3 AQUIVIH-NA Cohort-QuAliCOV Study)

Author:

Ben Farhat Jihane12ORCID,Hessamfar Mojgan234,Farbos Sophie5,Desclaux Arnaud6,Dumondin Gilles7,Ferrand Hélène8,Greib Carine9,Castan Bernard10,Rispal Patrick11,Duffau Pierre412,Leleux Olivier13,Perrier Adélaïde13,Wittkop Linda131415,Bonnet Fabrice2413,Barger Diana2

Affiliation:

1. Department of Epidemiology and Training, Epicentre, Médecins Sans Frontières, Paris, France;

2. Univ. Bordeaux, INSERM, BPH, U1219, Bordeaux, France;

3. CHU de Bordeaux, COREVIH Nouvelle Aquitaine, Bordeaux, France;

4. CHU de Bordeaux, Service de Médecine Interne et Maladies Infectieuses, Bordeaux, France;

5. CH de la Côte Basque, Service de maladies infectieuses, Centre Hospitalier de la Côte Basque, Bayonne, France;

6. CHU de Bordeaux, Service des Maladies Infectieuses et Tropicales, Bordeaux, France;

7. CH de François Mitterrand de Pau, Pau, France;

8. CH de Libourne Robert Boulin, Libourne, France;

9. CHU de Bordeaux, Service de Médecine Interne, Pessac, France;

10. CH de Périgueux, Service de Médecine Polyvalente, Périgueux, France;

11. Centre Hospitalier Agen-Nérac, Agen, France;

12. Department of Immunology, UMR 5164, ImmunoConcEpT, CNRS, Bordeaux, France;

13. Univ. Bordeaux, INSERM, Institut Bergonié, BPH, U1219, CIC-EC 1401, Bordeaux, France;

14. INRIA SISTM team, Talence, France; and

15. CHU de Bordeaux, Service d'information médicale, INSERM, Institut Bergonié, CIC-EC 1401, Bordeaux, France.

Abstract

Objectives: The COVID-19 pandemic's impact on initiation and effectiveness of antiretroviral therapy (ART) in people diagnosed with HIV remains unclear. We evaluated critical delays in HIV care in people diagnosed before and during the pandemic in ex-Aquitaine, France. Methods: We considered adults diagnosed with HIV-1 in 2018–2021 and enrolled in the ANRS CO3 AQUIVIH-NA and followed them until October 10, 2022 for those diagnosed during the pandemic (April 01, 2020–December 31, 2021) and until March 31, 2020 for historical controls. We compared their characteristics at inclusion and the median time between diagnosis and ART initiation, ART initiation and viral suppression, and diagnosis and virologic, suppression (effective management). Results: Eighty-three individuals were diagnosed during the pandemic versus 188 during the prepandemic period. Median follow-up was 549 (interquartile range: 329–713) days. Populations were similar in sex, age, HIV acquisition mode, hospital type, and clinical characteristics at diagnosis; however, fewer were foreign-born during the pandemic (15.7% versus 33.5%, P = 0.003). The probability of ART initiation, therapeutic success, and effective management was higher in people living with HIV (PLWH) diagnosed during the pandemic in adjusted analyses (hazard ratio [HR]: 2.0; 95% CI: 1.5 to 2.7; HR: 1.7; 95% CI: 1.2 to 2.3; HR: 1.8; 95% CI: 1.3 to 2.6, respectively). Those diagnosed during the pandemic were 2.3 (95% CI: 1.2 to 4.1) times more likely to be virologically suppressed within six months of diagnosis compared with historical controls. Conclusions: Pandemic-related reorganizations may have resulted in newly diagnosed PLWH being prioritized; however, the lower proportion of foreign-born PLWH diagnosed during the pandemic period, likely because of reduced migration and potential delays in diagnosis, may contribute to these preliminary findings.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Infectious Diseases

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3